Director

Matthew Fleischman, PhD is a Licensed Psychologist in Eugene , Oregon. Matt was Principal Investigator on an NIMH grant on the implementation of behavioral family treatment programs in several protective services units in Oregon that achieved an 80% reduction in out-of-home placements. In 1989 he was introduced to neurofeedback by Dr. Gene Peniston, a pioneer in the field. Matt has taught in the US and abroad on the integration of neurofeedback and behavior therapy. Over the course of his career he has worked with many modalities of neurofeedback including qEEG-based protocols, LENS, pirHEG, SMR/beta range training and Infra Low Frequency neurofeedback .

FINANCIAL DISCLOSURE

The Neurofeedback Advocacy Project is a 501 c3 non-profit. It is a voluntary undertaking of Dr. Fleischman. Dr. Fleischman does not have any financial ties to or investments in any neurofeedback-related business.

Consultants

The Neurofeedback Advocacy Project would not have been possible without the advice and support of the following:

Darla A. Meulemans, MA, CADC III, OMC is director of Mind Potential Northwest and a trainer for EEG Info. She is a dedicated role model, professional mentor and life coach, a Certified Neurofeedback Practitioner and Othmer Method Mentor, and her work is dedicated to promoting health & wellbeing, along with a philosophy of living that fosters fulfillment and harmony in life.

Grayce Stratton, PsyD of Lifetime Development, is a Psychologist with longtime experience with and commitment to neurofeedback.

Siegfried Othmer, PhD, Chief Scientist at the EEG Institute. He and with his wife Susan Othmer are the principle developers of InfraLow Frequency, the model used in this project.

Kurt Othmer is the CEO of EEG Info, the developers of the Cygnet neurofeedback system used in this project. Kurt has provided invaluable support, consultation and equipment without which this project would not have been possible.

Charlie Doe, FSA, MAAA a retired group health actuary. Charlie has been invaluable helping us organize our data collection to highlight the cost/benefits of NFB for the larger healthcare system.